RJ Reynolds
An Estimate of Adult Mortality in the United States From Passive Smoking.
Fields
- Site
- Dobbins Db
- Secretary
- R&D
- Biochem Biobehavioral-Sci Affairs
- Secretary
- Characteristic
- Marginalia
- Type
- PUBLISHED DOC
- Box
- Rjr2237
- Request
- Minnesota
- 1rfp93
- Author
- Environment Intl
- Pergamon Press
- Wells, A.J.
- Pergamon Press
- Date Loaded
- 27 Feb 1998
- UCSF Legacy ID
- dqu63d00
Document Images
Environme.u lnuernational. Vol. 14. pp. 249-265. 1988
Printed in the USA. All rights reserved.
AN ESTIMATE OF ADULT MORTALITY IN THE
UNITED STATES FROM PASSIVE SMOKING
A. Judson Wells
102 Kildonan Glen. Wilmington, Delaware 19807. USA
(Received 9 December 1987; Accepted 7 July 1988)
Ij '~~ , 1S J1
uIGU.Jl2o.'xR S3.twl , .(K)
Copyright .C 1988 Pcrpmon Press plc
NOTIt;E
This matotial msy be
Votected by CWl&
i4w (iitte 17 U.S. We).
The purpose of this paper is to estimate the number of adult deaths per year in the United States
from
passive smoking. The epidemiological literature on passive smoking and adult mortality and cancer
and
hean morbidity is reviewed. Combined relative risks (or lung cancer, cancers other than lung. and
heart disease are calculated for each sex and disease category. These data along with estimates of
nonsmoker death rates and populations exposed allow calculation of annual deaths in each ca4egory.
Reduced relative risk and reduced exposure at older ages are taken into account as well as a
correction
for possible misclassification of smokers as nonsmokers and exposed nonsmokers as nonexposed. Al-
together 46.000 deaths per year are calculated consisting of lung cancer (3000) other cancer
(11.000)
and hean disease (32.000). Reasons why such high estimates for other cancer and hean disease may
be possible are explored. It is concluded that exposure to environmental tobacco smoke can have
adverse long term health effects that are more serious than previously thought.
Introduction
Several attempts have been made to estimate U.S. adult
mortality from passive smoking. For example. Repace
and Lowrey (1985) estimated the lung cancer deaths to
be about 5000 per year. Fong (1982) estimated total
mortality at 10.000 to 50,000. Russell et al. (1986) es-
timated total U.S. mortality at more than 4000. The
present estimate is based on epidemiological evidence
currently available on lung cancer, cancers other than
lung. and heart disease.
The Surgeon General of the United States (USSG.
1986) and the U.S. National Academy of Sciences
(NRC, 1986) have issued reports stating that passive
smoking can cause lung cancer. In the National Acad-
emy report the relative risks from the various lung can-
cer studies were combined into an overall relative risk
using a procedure somewhat similar to that which is
used in this work. The Academy report then projects
that about 20% of the 12,000 U.S. lung cancer deaths
per year among never smokers is due to passive smok-
ing. This is reasonably close to the 3000 per year pro-
jecte.d here for never smokers plus exsmokers. The
.
methods used in the National Academy report are fur-
ther detailed in Wald et a!. (1986). Blot and Fraumeni
(1986) have also presented an overview of studies of
lung cancer and passive smoking. They use a method
of combining the relative risks from various studies es-
sentially identical to that used here. Thus, the proce-
dure of combining relative risks from various passive
smoking studies to obtain overall relative risks and
tighter confidence'intervals is now well established by
authorities in the field. Also, the method used here to
calculate annual deaths from the relative risks appears
to be validated by the National Academy results for
lung cancer. However, both the Surgeon General's task
force and that of the National Academy felt that the
data, as of 1986, on cancers other than lung and on
heart disease were still too meager to allow calculation
of reliable overall risks.
Since 1985 considerably new epidemiological infor-
mation has become available, particularly on heart dis-
ease. This new information is reviewed and combined
with the old data to calculate updated relative risks,
overall confidence "limits, and estimated annual U.S.
deaths from passive smoking and the three main dis-
eases, namely, lung cancer, cancers other than lung,
and ischemic heart~yI~ar' The total particulate matter
i"
dose retained by p 3~ve smokers is too low to account
for the health eKe; s ol Oassive smoking if one starts
with the health effe s exhibited by direct smokers and
ratios down from,t e dose retained by them. Reasons
why such a discrep ncy might occur are explored.
249

,50 r , A. J. wells
.
Methods -
Studies to be considered in the analyses were ob-
tained originally from the literature searches of the U.S.
Office on Smoking and Health (OSH, 1979-85). More
recently. studies have come to light primarily through
personal contact with workers in the passive smoking
field. Criteria for admitti~"g data to the analysis are:
1. Studies on the association of passive smoking with
adult mortality or morbidity from lung cancer, other
cancer or ischemic heart disease were included. All
cause data were not used because essentially no male
data are available. The female data, if calculated,
yield overall results that are in the same range as
the results derived from the three main diseases (see
Appendix B). Emphysema is not included because
the nonsmoker death rate is so low that less than
1% of deaths from passive smoking would be pre-
dicted from this source (see Appendix B).
2. Retrospective studies should have controls.
3. Observations should be based on spouse exposure
or on general exposure of more than 10 years du-
ration. The diseases under study are known to have
long induction periods, and it is assumed that most
married people old enough to die of passive smoking
would have been exposed 20 years or more.
4. Enough data should be available from the study to
allow calculation of a weighting factor for combining
the relative risks.
Two risk models were used and a third was consid-
ered. The primary model used combined relative risks
from the various studies that pertained to a given sex
and disease and assumed that the combined relative risk
was constant with age, although variation with age of
the underlying neversmoker death rate and the fraction
of the population exposed were included. In the sec-
ondary risk model the combined relative risk was also
allowed to vary with age. These models were suggested
in part by the considerations in James Robins' Appen-
dix D in the National Academy report (NRC, 1986).
The third risk model was based on the rate difference
between the death rates for exposed and nonexposed
populations. A detailed analysis of this model for heart
disease in women was carried out (see Appendix C). It
was concluded that the relative risk models were much
superior to the rate difference model when combining
data across different cultures as is the case here where
some of the studies are from the orient.
Wherever a study showed both a crude relative risk
or odds ratio and an adjusted ratio, the adjusted ratio
was used. To obtain a combined relative risk a method
similar to that of Blot and Fraumeni (1986) was used.
Case control studies were aggregated using Program 2
of Rothman and Boice (1982). Cohort studies were ag-
gregated using Program 7. A combined relative risk for
the two aggregates was obtained using:
Rte s expw`°InR,, + w«InRn (1)
K'co + K'cc
where &; Rro, and RK are the relative risks for the
combined total, the cohort studies, and the case control
studies, respectively, and w,, and w« are the weights
for the cohort aind case control studies. respectively.
which are the inverse of the respective variances. Vari-
ance is taken as the square of the standard deviation
which is equal to In R/x, so the weight, w=(X/In R)'-.
The source of these equations is Rothman (1986). Con-
fidence intervals were calculated from a combined X=
w'"- In RN.'fior some studies it was necessary to calculate
a chi from the confidence limits in order to calculate a
weight since no other data were available. These data
were then combined with the rest using Eq. (1). Ages
of death from 35 and up were used and should include
essentially all adult deaths from passive smoking. In
some studits morbidity relative risks were reported
whereas our interest is in mortality. The morbidity rel-
ative risks were accepted as surrogates for mortality
relative risks because, for cancer, the survival rates for
exposed and nonexposed cases appeared to be similar
while, for heart disease, incidence relative risks, if any-
thing, are lower than mortality relative risks (Svendsen
et al., 1987).
The 1985 smoking status for U.S. residents in 5 year
age increments was obtained from the National Center
for Health Statistics. Nonsmokers were equated to
never smokers plus exsmokers. The fractions of never
smokers living with ever smokers (24% for mates and
60% for females), all of whom were considered to be
exposed, were obtained from controls of the U.S. based
studies for all three diseases. These fractions were as-
sumed to hold also for nonsmokers (never plus ex). The
fractions of all nonsmokers exposed as nonsmokers liv-
ing with nonsmokers, but still exposed at home or at
work (37% for males and 16% for females), were ob-
tained from Friedman val. (1983). These fractions were
assumed to hold for nonsmokers living with never smok-
ers. By adding the two fractions the total nonsmoker
exposure of 61% for males and 76% for females was
obtained. These overall exposure fractions are known
to be higher at younger ages and lower at older ages.
The data of Friedman etal. (1983) were used to develop
smoothed values of fraction exposed 10 years earlier
(midpoint of `a 20 year exposure) for each sex and 5
year age interval normalized to 61% for males and 76%
for females. by multiplying each population element
by.each fraction exposed element, the exposed popu-
lation by sex and 5 year age interval could be deter-
mined.
Death rates for never smokers for lung cancer by sex
and 5 year intervals were drawn from Garfinkel (1981)
50986 1060

.
I
,
I Adult mortality from passivc smoking
and smoothed using a semi-log plot against age. For
cancers other than lung-for females a semi-log plot of
1984 age specific death rates for ages 35 + was devel-
oped for'malignant neoplasms less malignant respira-
tory neoplasms from the data of the National Center
for Health Statistics (1986). Then, a parallel plot was
developed using as reference points the neversmoker
data of Hammond (1966) for ages 45-64 and 65-79 to
yield neversmoker rates for ages 35+ for each 5 year
age interval. For heart disease never smoker death rates
by sex and 5 year age intervals for 1963 were developed
from the appendix tables in Hammond (1966). These
were reduced to 1984 equivalent iates (with the reduc-
tion factors corrected for the effects of smoking) by a
technique similar to that used by the U.S. Office of
Technology Assessment (OTA, 1985). Semi-log graphs
were used to estimate never smoker death rates by 5
year age intervals for the entire age range (see Appen-
dix A. Table A3).
The excess death rate for never smokers for passive
smoking (D,,,) for each sex. disease and 5 year age range
was calculated from the never smoker death rates (D,v)
using the formula:
Do, = D,JR - 1)l(Fo(R - 1) + 1) (2)
where Fo is the fraction of the population that is exposed
and R is the combined relative risk. This excess death
rate was assumed to apply to all nonsmokers. Deaths
were then calculated by multiplying the passive smoking
excess death rate by the exposed population for each
sex and 5 year age interval, and summed. For those
calculations where the relative risk was assumed to have
varied with age, the excess death rates for passive smok-
ing were recalculated from the age specific relative risks
for each 5 year age interval. Additional calculations
were carried out to show the effects of bias including
those from misclassification of smokers as nonsmokers
and exposed nonsmokers as unexposed, using a method
similar to that of Wald et at. (1986).
Results
Relative risks
The results for passive smoking relative risk for fe-
males for lung cancer are shown in Table 1. The three
cohort studies are listed first and show a combined rel-
ative risk for all exposures including exposures to
exsmokers of 1.34. At the time the analysts was made
there were fourteen acceptable case control studies with
a combined relative risk of 1.50. The overall combined
relative risk, based on 1,174 cases, is 1.44 with 95%
confidence limits of 1.3-1.7. The male lung cancer ob-
served relative risks are shown in Table 2. There are
now nine studies with 144 total cases. The overall com-
bined relative risk is 2.1 with 95% confidence limits of
251
1.3-3.2. Data excluded from Tables'l and 2 along with
the reasons were the following: Chan et at (1979), cur-
rent exposure only; Knoth cr al. (1983), no controls;
Kabat and Wynder (1984) nonspouse data, current ex-
posure only; Buffier et a1. (1984), 0-32 year data, not
a minimum bf 10 years exposure. A paper by Dalager
et al. (1986) describes a pooling of data from Correa et
at (1983), Buffler et at (1984) and a study of males in
New Jersey. ; I'hey observed an adjusted odds ratio for
spouse exposure of 1.47, but since Correa et at (1983),
and Buffler tt at (1984), were already included in Ta-
bles I and 2 and since the New Jersey data were not
available separately, it was decided to omit the Dalager
et at. (1986),study from this analysis. Also. available
were abstracts of two recent papers. Geng et at. (1987)
from China t+vith a relative risk of 2.2 and Inoue and
Hirayama (1087) from Japan with a relative risk of 2.3,
both for females. Also W. K. Lam (1985) in a thesis
from the University of Hong Kong that is quoted in
Lam et al. (1987) found a relative risk of 2.0 for ad-
enocarcinoma among females. These inputs arrived too
late to be included in the analysis. .
The data of Hirayama (1984a) on female lung cancer
are sufficiently detailed to indicate a declining relative
risk with age from 1.87 at approximately age 50 to 1.43
at approximately age 75. These data were used to de-
velop a second death calculation assuming a declining
relative risk, but still normalized to 1.44. However,
Hirayama's data show no such decline in passive smok-
ing relative risk with age for males. Instead, the trend
appears to rise with age, so no secondary calculation
was made.
There are now five studies relating passive smoking
to total cancer or cancer other than lung in females.
The individual and combined relative risks for females
are shown in Table 3. The total combined relative risk
is 1.16. The total cases, 2,933, are two and one-half
times the total cases for female lung cancer (Table 1)
although 2,505 are concentrated in the large Hirayama
(1984a) study.'This is a large data base. The total com-
bined chi square is 11 compared to 27 for female lung
cancer.
The two largest of the female studies. Hirayama
(1984a) and Sandler et a!. (1985), cover different age
of death ranges. Hirayama covers 50 to 80+ while
Sandler et al. cover <30 to 59. The two studies taken
together would indicate a rather sharp decline in rela-
tive risk with age from about 3.5 at age 40 to about 1.04
at age 80. The' high relative risks at the younger ages
may be due to premenopausal breast cancer (see San-
dler et al., 1986). Two calculations of U.S. female
deaths from passive smoking and other cancers were
made, one using the 1.16 relative risk from Table 3 at
all ages and one using the declining relative risks.
Gillis et al. (1984). Sandler et al. (1985). and Rey-
nolds (private communication) also report on other can-
50986 1061

252
Table 1. Female relative risks for lung cancer from passive smoking. A. J. Wells
.
T Highest
Exposure All
Exposures Mantel
Trend
Locale otal
Cases
RR
2-tail p
RR
95 % C.L.
1-tail p
Cohort Studies:
Hirayama (1984a)
Ja¢5n
200
1.9
0.002
1.6
1.1- 2. 2
0.002
Garfinkel (1981) United States 153 1.1 - 1.2 0.8-1.6 -
Gillis er a1.'(1984) Scotland 8 1.1 0.2-5.6
Combined Cohort 361 1.34 1.1-1.7
Case Control Studies:
Trichopoulos et at. (1983)
Greece
77
2.6
0.19
2.1
1.2-3.6
0.005
Correa et al. (1983) Louisiana 22 3.5 0.02 2.1 0.8-5.2
Buffler et at. (19&1) Texas 27' - - 0.9 0.4-2.3
Kabat and Wynder (1984) United States 24 0.8 0.3-2.5
Sandler et al. (1985)
Garfinkel et al. (1985) North Carolina
United States 2
116
2.0
0.05 inf
1.3
0.8-1.9
0.025
Wu er al. (1985) California 28' 1.2 0.5-3.3
Lee et al. (1986) United Kingdom 32 - - , 1.0 0.4-2.7
Akiba et al. (1986) Japan 94 2.1 - 1.5 0.9-2.6 0.06
Koo ct at. (1987) Hong Kong 86 1.2 - 1.6 0.9-3.1
Pershagen et a!. (1987) Sweden 67 3.2 - 1.2 0.7-2.1 0.12
Humble et al. (1987) New Mexico 20 1.2 -- 2.3 0.9-6.6
Brownson et al. (1987) Colorado 19 - - 1.7 0.4-3.0
Lam et al. (1987) Hong Kong 199 1.65 1.2-2.4
Combined Case Control 813 1.50 1.3-1.8
Combined Cohort and C/C 1174 1.44 1.26-1.66
' Private communication.
'From Blot and Fraumeni (1986).
cer in males. The relative risks were 0.6. 1.5 and near
unity, respectively. The number of cases in each study
is very small with no statistical significance. Therefore,
it was decided to use a neutral relative risk of 1.0 for
males for cancer other than lung until more data become
available.
There are now six studies of passive smoking and
heart disease in females. The individual and combined
relative risks are shown in Table 4. Studies new since
1985 are Lee et dl. (1986), Martin et al. (1986a) and the
important, largeHklsing et al. (1988) paper from Mary-
land. The overall combined relative risk based on 1.622
cases is 1.23 with 95% confidence limits of 1.11 to 1.36
and a combined phi square of 16. Helsing et al. (1988)
and Martin et al. (1986a) provide data for younger
women and indicate high relative risks (average 2.45)
Table 2. Male relative risks for lung cancer from passive smoking.
Locale Total
Cases
RR
Cohort Studies
Hirayama (1984a)
Japan
64
2.3
Gillis et at (1984) Scotland 6
Combined Cohort 70
Case Control Studies:
Correa et at (1983)
Louisiana
8
Buffler et at (1984) Texas 8'
Kabat and Wynder (1984) United States 12
Lee et at. (1986) United Kingdom 1S
Akiba et at (1986) Japan 19
Humble et at (1987)' New Mexico 8
Brownson et at (1987)' Colorado 4.
Combined Case Control 74
Combined Cohort and C/C 144
'Private Communication.
Highest
Exposure
2-tail p,
0.16
All
Exposures Mantel
Trend
RR 95'k C.L. I-tail p
2.25 1.11- 4.9 0.023
3.3 0.7 -16.5
2.5 1.2 - 5.0
2.0 0.4 -10
1.6 0.3 - 8.1
1.0 0.3 - 3.2
1.3 0.4 - 4.6
1.8 0.5 - 5.6
4.2 1.0 -16.8
2.7 0.2 -31
1.$ 1.0 - 3.3
2.1 1.3 - 3.2

, Adult mortality from passive smoking 253
. Table 3. Female relative risks for cancer other than lung"from passive smoking.
Highest All Mantel
Exposure Exposures Trend
Locale Total
Cases
RR
2-tall p
RR
95 % C.L.
1-tail p
~..._.
Cohort Studies:
Hirayama (1984a)' y.
Japan
2505
1.16
0.01
1.11
1.0 -1.2
0.05
Gillis et al. (1984) Scotland 43 - - 1.2 0.6 -2.5 -
Reynolds ei al. (1987) California 70° 1.7 1.1 -2.7
I Combined Cohort 2618 1.13 1.03-1.24
Case Control Studies:
Miller (1984Y
Pennsylvania
84
1.25
0.7 -2.3
Sandier et a!. (1985) North Carolina 231 2.0 1.3 -2.9
Combined Case Control 315 1.7 1.2 -2.45
Combined Cohort and 2933 1.16 1.06-1.27
C!C
I
t
'Obtained by subtracting data for lung cancer from data for all sites.
'Provided by Dr. Reynolds.
'Age adjusted Mantel-Haenszel values for nonemployed wives.
for ages up to about 50. At higher ages there is no trend
with an average relative risk of 1.17 holding out to
age 84.
For male heart disease and passive smoking there
are now four studies (see Table 4). The two new ones
are Lee trt al. (1986) and Helsing et al. (1988). The result
of Svendsen et al. (1987) is shown for information, but
is not used in calculating the combined relative risk
because it pertains to a high risk group. The combined
relative risk based on 443 cases is 1.31 with 95% con-
fidence limits of 1.1 to 1.6 and a combined chi square
of 9. The results are remarkably uniform. As in the
female data the relative risk is high at the younger
ages, about 2,.9, but declines to a nontrend average of
1.28 which extends from age 55 out to the older ages.
Svendsen et al. (1987) show that there was very little
difference between never smoking men married to
nonsmokers and those married to smokers in the major
coronary risk factors such as baseline blood pressure,
total cholesterol, and LDL cholesterol. This work was
reported in more detail in Martin et al. (1986b). Small
differences were found in weight (195 vs. 190 if wives
were smokers) and drinks per week (10 vs. 8 if wives
were smokers). On the other hand, Garland et a!. (1985)
Table 4. Relative risks for heart disease from passive smoking.
Highest All Mantel
Exposure Exposures Trend
Locale Total
Cases
RR 2-tail p
RR
95 % C.L.
1-tail p
I
t Females
Cohort Studies:
Hirayama (1984b)
apan
94
.3 0.038
.16
.9- 1.4
.02
Gillis et a!. (1984) Scotland 21 3.6 0.9-13.8
Garland et al. (1985) California 19 - 3.5 0.9-13.6
Helsing et al. (1988) Maryland 988 1.27 - 1.24 1.1- 1.4 0.005
Combined Cohort 1522 i 1.23 1.1- 1.4
Case Control Studies:
Lee et a!. (1986)
United Kingdom
77
0.9
0.7- 1.3
Martin et a!. (1986a) Utah 23 2.6 1.2- 5.7
Combined Case Control 100 1.29 0.8- 2.0
Combined Cohon and C/C 1622 1.23 1.1- 1.4
Ma/es
Cohort Studies:
Gillis et a1. (1984)
Scotland
32
1.30
0.7- 2.6
Lee et al. (1986) United Kingdom 41 1.24 0.5- 2.6
Helsing et a/. (1988) Maryland 370 1.31 1.1- 1.6
Combined Cohort 443 1.31 1.1- 1.6
Svendsen et al. (1987)° United States 13 2.2 0.7- 6.9
'Based on Cochran chi-square of 9.2.
MRFIT cohort of high risk individuals, included for information only.
50986 1063

.
.
found that never smoking women married to smokers
had slightly lower weight, slighily lower blood pressure,
and slightly higher cholesterol, all nonsignificantly dif-
ferent, versus never smoking women married to never
smokers. All of these authors conclude that the in-
creased passive smoking risks they observed cannot be
ascribed to differences in the m.pjor coronary risk fac-
tors between passively exposed and nonexposed never
smokers.
It is impressive that the relative risks for heart disease
from passive smoking rise in an orderly manner from
the lowest risk group. Japanese women at 1.16, through
American women at 1.27, and American men at 1.31,
to high risk American men at 2.2.
A correction for misclassification was attempted for
all three disease categories. Following Wald et al.
(1986), and presuming that the passive smoking studies
were done somewhat more carefully than the general
questionnaire studies they cite, it was assumed that 5%
of ever smokers were misclassified as never smokers.
Along with Wald et al. (1986) we assumed that the
nonexposed nonsmokers were actually exposed to 1/3
the extent of the exposed nonsmokers except that for
Greece. Japan, and Hong Kong, where less than 30%
of women had ever smoked, the correction for nonex-
posed female nonsmokers was omitted. It is believed
that older. nonsmoking women in Greece and Japan,
and probably in Hong Kong also. because of their social
habits, were exposed to relatively little tobacco smoke
beyond that of their husband's. Since most of the mis-
classified smokers were found to be light smokers or
longstanding exsmokers, reduced relative risks for the
misclassified ever smokers were calculated, as noted in
Appendix A. The modified passive smoking relative
risks are shown in Table 5. The false relative risks due
to smoker misclassification are somewhat lower than
calculated earlier by Wells (1986) because of the as-
sumption of light smokers and long term exsmokers
among those misclassified. following Wald-eral. (1986),
and the use of a more accurate formula. In general, the
misclassification of smokers has a large negative effect
on male relative risk which is more or less offset by the
positive effect of exposure of the "nonexposed." For
females the smoktr,misclassification effect is small fo
negligible, but because the relative risks are smaller and
no correction was made to "eastern" data (Japan.
Greece, and Hong Kong), the positive effects of ex-
posure of "nonexpo$ed" are also smaller.
Calculation of Deaths
The details for the calculation of female lung cancer
deaths from the relative risks, both constant and de-
clining, are shown°in Table 6 as an example. Similar"
calculations were made for the other disease and sex
categories and are 'shown in Appendix A. The results
of all of the calculations are summarized in Table 7.
These results are restated per million total population
in Table 8. Where khe relative risk appears to decline
with age and where neversmoker death rates at the
younger ages are low, as in female heart disease and
lung cancer, there is a reduction in mortality calculated
by using the age specific relative risks. Otherwise, the
higher exposed population at the younger ages out-
weighs the higher death rate at older ages and total
mortality is increased. In terms of total deaths the ef- fects of using age specific relative risks
tend to cancel
out. The total deaths, before adjustment for misclas-
sification, for both males and females are about 19,500
for a total for both sexes of about 39,000.
The effects of misclassification on total deaths are
substantial, raising the total to 53,000. Most of this
increase is in heart disease where the numbers are large
and the effects of smoker misclassification. although not
necessarily small, are still heavily outweighed by the
partial exposure of the "nonexposed."
To be conservative a best estimate for passive smok-
Table 5. Passive smoking relative risks modified for misclassification.
A. J. Wells
Lung Cancer Other Cancer Heart Disease
Females
1. Combined relative risk. 1.44 1.16 1.23
2. False relative risk due to projected 5%
smoker misclassification.
1.01
1.002
1.01
3. Combined relative risk corrected for
smoker misclassification, (1) + (2).
1.43
1.16
1.22
4. (3) corrected for exposure of "non
exposed" at 1/3 that of exposed.
1.48
1.21
1.32
Males
1. Combined relative risk.
2.1
1.01
1.31
2. False relative risk due to projected 5%
smoker misclassification.
1.3
1.11
3. Combined relative risk corrected for
smoker misclassification. (1) + (2).
1.6
1.17
4. (3) corrected for exposure of "non-
exposed" at 1/3 that of exposed.
2.4
1.29
'Assumed value for lack of better data.

' Adult mortality from passive smoking 255
Table 6. Annual U. S. female lung cancer deaths from'passive smoking.
d
E Relative Risk
Constant at 1.44 Relative
Risk
D
li
i
Age of
Death Neversmoker
Death Rate
per 100.000 f' Nonsmoker
Population
1000's
Fraction
Exposed xpose
Population
1000's
Excess
Death Rate Deaths
RR ec
n
ng
Deaths
35-39 1.6 6150 0.94 5781 0.50 29 1.70 39
i0-44 4
2 4622 0.92 4252 0.75 32 1.69 43
t
1
45-49 .
3.6
3846
0.89
3423
1.14 39
1.68
52
50-54 5.3 3856 0.87 3355 1.69 57 1.62 72
55-59 7.8 4161 0.84 3495 2.51 88 1.56 104
60-64 11.0 4192 0.77 3228 3.62 117 1.49 126
65-69 16.6 4160 0.70 2912 5.55 162 1.43 159
70-74 23.5 3441 0.59 2030 8.21 167 1.36 142
75-79 34 3004 0.49 1472 12.3 181 1.29 127
80-84 46 1886 0.29 547 18.0 98 1.18 43
85 + 52 1003 0.10 l00 21.9 22 1.0(t 4
Totals 13.0 40291 0.76 30595 3.0 992 - 911
ing deaths might be 46,000. half way between the 39.000
calculated directly from the relative risks and the 53.000
calculated using the modified relative risks. By disease
the total would consist of 3,000 lung cancer. 11,000
other cancer, and 32,000 heart disease. For each million
of total population the deaths by disease would be 13
for lung cancer. 46 for other cancers, and 134 for heart
disease. These numbers may be useful for populations
similar to that of the United States in terms of propor-
tions of never smokers, exsmokers, and smokers, and
in terms of the proportion of the population that is less
than 35 relative to that over 35. For other populations
the per million numbers are best not used, but the meth-
odology can be used. That cancer other than lung and
heart disease are legitimate contributors to deaths from
passive smoking is supported in Hirayama. (1984a,b)
in his large prospective study. He found significantly
elevated risks for all three diseases. and his result for
lung cancer is now believed to be valid. (USSO 1986;
NRC, 1986). It is difficult to believe that his lung cancer
result is valid while the other two are not.
Discussion
The cancer sites for passive smoking appear to differ
somewhat from those for direct smoking. Using infor-
mation on specific cancer sites from Dr. Hirayama (pri-
vate communication) it appears that cancers common
to both types bf smoking are lung, liver, cervix, nasal
sinus, and leukemia. Some of these cancers are on1Y
weakly associated with direct smoking. Cancers asso-
ciated to som degree with direct smoking, but absent
in passive sm~king are buccal cavity. pharynx, larynx.
esophagus, stomach (Hirayama, 1984a), urinary blad-
der (Kabat et 01., 1986), kidney and pancreas. Cancers
related to passive smoking, but absent in direct smoking
are brain (Hirayama.1984a), endocrine glands (Sandler
et aL,1985), lymphoma and breast (Sandler el a1.,1985.
1986; Hirayama, private communication). The first
three are significant at the 95% level. The combined
breast relative'rtsk of 1.4 is significant at only 88%.
Higher relative risks for these four sites might be found
for direct smoking if epidemiologists used nonpassively
Table 7. Summary: U.S. annual deaths from passive smoking.
Lung
Cancer Other
Cancer Hean
Disease
Total
Females:
1. Constant combined relative risk. 992 8599 9768 19359
2. Relative risk declining with age. 911 11165 7602 19678
3. (1) corrected for misclassification. 1232 12280 14995 28507
Males:
1. Constant combined relative risk.
1606
0
17335
18941
2. Relative risk declining with age. 1606 0 18164 19770
3. (1) eorrected for misclassification. 2499 0 22467 24966
Totals for both sexes:
1. Constant combined relative risk.
2598
8599
27103
38.';00
2. Relative risk declining with age. 2517 11165' 25766 39448
3. (1) corrected for misclassification. 3731 12280 37462 53473
Best current estimate, both sexes (rounded). 3000 11000 32000 46000

~ .
Table 8. Summary: Deaths per million population in U.S. from passive smoking. . .
' - (based on 239.000.000 U.S. population in 1985).
Lung
Cancer Other
Cancer Heart
Disease
Total
_._,....
Females:
1. Constant combined relative risk.
4.15
35.98
40.87
81.00
2. Relative nsk declining with age. 3.81 46.11 31.81 82.33
3. (I) corrected for misclassification. 5.15 51.38 62.74 119.27
Males:
I. Constant combined relative risk.
6.72
0 '
72.53
79.25
2. Relative risk declining with age. 6.72 0 76.00 82.72
3. (1) corrected for misclassification. 10.46 0 94.00 104.46
Totals for both sexes:
1. Constant combined relative risk.
10.87
35.98
113.40
160.25
2. Relative risk declining with age. 10.53 46.71 107.81 165.05
3. (1) corrected for misclassification. 15.61 51.38 156.74 223.73
Best current estimate, both sexes (rounded). 13 46 134 193
J
256 A
Wells
exposed never smokers as the referrent category rather
than all never smokers as is usually done. Another dif-
ference between passive smoking and direct smoking is
that the ratio of lung cancer deaths to deaths from other
cancer for females or from heart disease for both sexes
is much lower in passive smoking than in direct smok-
ing.
These differences in mortality effects are probably
real and reflect differences in chemistry and physics
between direct smoking and passive smoking. Environ-
mental tobacco smoke is generated in the burning tip
of the cigarette at a lower temperature than direct
smoke and therefore contains higher proportions of
complicated organic compounds that tend to be carcin-
ogenic (Brunnemann et al., 1978). More importantly,
(see Appendix D) the mainstream smoke, although
generated at a particle size of about 0.7 µm, is very
concentrated and appears to agglomerate into larger
particles. Deposition rates are high, about 80%. De-
position occurs primarily in the mouth or in the larger
airways of the lung where the particles are cleared rel-
atively quickly into the mouth. This material is then
swallowed. Some of it may be eliminated and produce
no health effects at all or it may cause the digestive
type cancers observed. Only a portion of mainstream
smoke appears to remain as small particles that can
penetrate deeply into the alveolar region. Environ-
mental tobacco smoke, on the other hand, is very dilute,
with a mass median diameter of about 0.4 µm. Particles
in this size range have very low deposition rates, on the
order of 10%, but what does deposit does so deep in
the alveolar region of the lung where clearance times
are longer. Black and Pritchard (1984) estimate that
cigarette tar has a 17 hour half-time rate of clearance
from the alveolar region, much longer than clearance
times from the ciliated parts of the lung, but much
shorter than for inert particles. This means that smoke
particles are very likely dissolving in the fluids in the
alveolar region and are being cleared into the blood
and lymph systems for circulation throughout the body.
In summary, there are two types of smoking: (a)
large particle smoking, or its equivalent, which is the
major compon,ent of direct smoking, which results in
massive deposition in the mouth and larger airways of
the lung, rapid,clearance, cancers of the mouth. central
lung and digestive system. and possibly heart disease,
and (b) small particle smoking, which is a minor com-
ponent of direCt smoking, but the entirety of passive
smoking, and which results in low doses deep in the
lung, slow clearance, some lung cancer, but primarily
other cancers and adverse heart effects.
These differfnces in chemistry and physics also ex-
plain, at least in part. the rather high mortality observed
for passive smoking relative to the deposited dose of
particulate. Smoke retention by a passive smoker is only
about 1/400 that retained by a direct smoker in a 16
hour day (0.64 mg for the passive smoker per USSG
(1986, p. 196) and 240 mg for the direct smoker assum-
ing twenty 15 mg tar cigarettes and 80% retention). In
comparison, the ratio of lung cancer death rates is about
1/35. For cancers other than lung in females the ratio
is about 1/7, for heart disease in females about 1/ 14
and for heart disease in males about 1/3. Preliminary
calculations which are shown in Appendix D indicate
that the smoke retained deep in the alveolar region may
have a dose ratio higher than 1/400, perhaps as high as
1/60. It may be that carcinogenic material that solu-
bilizes and clears from the alveoli into the blood may
cause not only some of the cancers other than lung that
are observed in passive smoking, but also some of the
heart disease from passive as well as direct smoking.
The hypothesis of Benditt and Benditt (1973) that ar-
terial plaques are caused by DNA-modifying agents is
receiving increasing support. See, for example, the re-
cent work of Pe n tt al. (1986) on cell transforming
capability of hu n theroSclerotic plaque DNA and
the earlier work ~ A~bert et at (1977) and Penn et al.
(1981) on the for atiort of arterial plaques in cockerels
with dimethylbe z(a)ahthracene and benzo(a)pyrene.
Another possiN~ factor that might help explain the
disparate mortaiity tff4cts versus dose is the level of
disease susceptab,ility'itti `passive smokers versus direct
~

.
0.dutt moctatity (com passive smoking
257
smokers. The median age for passive smoking death
from lung cancer for males is 66 and the deaths con-
stitute 0.006% per year of the exposed population. The
first 0.006% of ma)e smokers have died of lung cancer
by age 46 at which age the lung cancer death rate is
doubling every four years. ikt age 66 the smoker lung
cancer death rate is doubling about every 13 years. In
other words, in passive smoking deaths we are dealing
with only the very most susceptible people, whereas in
direct smoking most of the victims are much nearer
average susceptibility. Similar considerations apply to
the other diseases here discussed.
A question often raised is that direct smokers are
also passive smokers, so why do they not get the passive
smoking related cancers. We have already pointed out
that the use of nonexposed never smokers as the re-
ferrent category for smoker relative risk would increase
the apparent risk for smokers. Another possible expla-
nation is the probability of competing risks. Most of the
highly susceptible direct smokers would have died in
their forties or fifties from smoking related disease and
would not be available to die of passive smoking related
disease in their sixties or seventies.
The passive smoking mortality calculated in this
study. namely, 46,000, may be low. Repace and Lowrey
(1985) calculate lung cancer deaths from passive smok-
ing at 4,665, or about 50% higher than our estimate,
primarily because of postulated intense exposure at the
workplace, a factor not taken into account in this study
since the relative risks are based largely on home ex-
posure. If Repace and Lowrey are correct, the higher
exposure would lead to corresponding increases in
deaths from heart disease and other cancer. Also, only
ischemic heart disease is considered here. As the all
cause data in Appendix B indicate, other cardiovascular
diseases and diabetes may be sensitive to environmental
tobacco smoke and may increase the total deaths.
The new epidemiological studies on passive smoking
support the earlier ones and indicate that not only lung
cancer, but other cancer and heart disease are serious
problems. In fact, lung cancer appears to be only the
tip of the iceberg. To be on the safe side public health
policy should be to protect nonsmokers from environ-
mental tobacco smoke.
Acknowledgemenrs - The author is grateful to Dr. T. Hirayama for
his data on individual cancer sites and for the details of his "all cause"
data. to R. W. Wilson of the U.S. National Center for Health Statistics
for data on the smoking status of U.S. residents by S year age inter-
vals. to L. Garfinkel for the person years in his 1981 study. to J. M.
Samet for data on mate lung cancer in the New Mexico study. to R.
C. Brownson for male lung cancer data in the Colorado study, to P.
Buffler for her 33+ year data, to Sir John Crofton for abstracts of
Lam a+ al. (1987) and Geng tr af. (1987). to P. Reynolds for the
number of cases in their study on female cancer, the number of lung
canccr cases. and their qualitative results on males, to D. P. Sandier
for nonsmoker data on breast cancer. and to S. C. Hunt for enough
data from Martin cr at. (1986a) to calculate an all-exposure relative
risk. confidence limits and a weighting factor. The author also wishes
to thank James Robins. N. A. Dalager. J. M. Samet. W. J. Blot. L.
C. Koo. A. H. Wu. G. Pershagen. D. P. Sandier. D. Trichopoulos
and J. L. Repace for helpful correspondence and discussion.
References
Akiba. S.. Kato. H.. and Blot. W. J. (1986) Passive smoking and
lung cancer among Japanese women. Cancrr Res 46. 48t1t-4807,
Albert. R. D.. Vanderlaan. M.. Burns. F., and Nishizumi. M. (1977)
Cancer Res 37, 2232-2235.
Balin, B. J. Broadwell. R. D.. Salcman. M.. El-Kalling. M. (1986)
Avenues for entry of peripherally administered protein to the
central nervou~system in mouse, rat, and squirrel monkey. J.
Comp Neurof 1, 260-280.
Benditt. E. P. and Bcnditt. J. M. (1973) Evidence for a monoclonal
origin of human atherosclerotic plaques. Proc Nail Acad Sci. 70.
1753-1756.
Black, A. and Pritchard. J. N. (1984) A comparison of the regional
deposition and short term clearance of tar particulate material
from cigarette smoke. with that of 2.5 µm polystyrene micro-
spheres, Aero><°ot Sci 1A. 224-227.
Blot, W. J. and traumeni. J. F. (1986) Passive smoking and lung
cancer. J Nar Cancer lnsr 77. 993-1000.
Brownson. R. C.. Reif. J. S.. Keefe. T. J.. Ferguson. S. W.. and
Pritzl. J. A. (1987) Risk factors for adenocarcinoma of the lung.
Am J Epidentlol 125. 25-34.
Brunnemann. K. b., Adams. J. D.. Ho. D. P. S.. and Hoffmann.
D. (1978) The Influences of tobacco smoke on indoor atmospheres
II. Volatile and tobacco specific nitrosamines in main and side-
stream smoke and their contribution to indoor pollution, in Pro-
eeedings, 4th'Joint Conjirence on Sensing of Environmental
Pollutants. N4w Orle,ns, Louisiana. 1977. American Chemical
Society. Washington. D.C., 876-880.
Buffler. P. A.. Pickle. L. W.. Mason. T. J.. and Contant. C. (19M)
The causes of lung cancer in Texas. in Lung cancer: Causes and
prevention. W{. Mizell and P. Correa. eds.. pp. 83-99. Verlag
Chemie Interrlational, New York.
Chan. W. C.. Colbourne. M. 1.. Fung. S. C.. and Ho. H. C. (1979)
Bronchial cancer in Hong Kong 1976-1977. B,J Cancer 39. 182-
192. Chan. W. C. and Fung. S. C. (1982) Lung cancer in non-
smokers in Hong Kong. in Cancer campaign. Vol. 6. Cancer Ep-
idemiotogy, E. Grundmann. ed., pp. 199-202. Gustav Fischer
Verlag. Stuttgart, New York.
Correa. P.. Pickle. L. W., Fonthan. E.. Lin. Y.. and Haenszel. W.
(1983) PassivtL smoking and lung cancer, l.ancer ti. 595-597.
Dalager. N. A.. PiCkle. L. W.. Mason. T. J.. Correa. P.. Fontham.
E.. Stemhageh, A.. tt at. (1986) The relation of passive smoking
to lung cancer. Cancer Res 46. 48(18-i811.
Fong, P. (1982)'J'he hazard of cigarette smoke to nonsmokers. J.
Biot. Phys 10; 65-73.
Freidman. G. O.; Petitti.. D. B., and Bawol. R. D. (1983) Prevalence
and correlates of passive smoking. Am J Public Health 73. 401-
405.
Fuchs. N. A. (1964) The Mechanics of Aerosols. pp. 46-49. Mac-
millan. New York.
Garfinkel. L. (1481) Time trends in lung cancer mortality among
nonsmokers and a note on passive smoking. J Nat Cancer Inst 66.
1061-1066.
GarGnkel. L.. Auerbach. O., and Joubert. L. (1985). Involuntary
smoking and lung cancer: A case control study. J Nar Cancer Insr
75.463-469.
Garland. C.. Barrett-Connor. E.. Suarez. L.. Criqui. M. H.. and
Wingard. D. L. (1985) Effects of passive smoking on ischemic
heart disease mortality of nonsmokers. Am J Epidcmiot 121. (.35-
650.
Geng. G. Y., l.iang. Z. H.. Zhang. A. Y., and Wu. G. L. (1987.
November) On the relationship between cigarette smoking and
female lung cancer. Paper presented at the 6th World Conference
on Smoking and Health. Tokyo.
Gerrity, T. R.. Lee. P. S., Hass. F J.. Marinelli. A.. Werner. P.. and
Lourenso, R, V. (1979) Calculated deposition of inhaled particles
in the airway generations of normal subjects. J Appl Ph}siol:
Respirar Environ Exercise Phvsiol 47. 867-873.
Gillis. C. R.. Hole. D. J.. Hawthorne. V. M.. and Boyle. P. (1984)
The effect of environmental tobacco smoke in two urban com-
munities in the west of Scotland. EurJ Resp Dis 65. (supplement
No. 133). 121-126.
Hammond. C. (1966) Smoking in relation to the death rates of one
million men and women. in Epidemiological Approaches to the
Study of Cancer and Other Chronic Diseases. W. Haenszel. ed..
pp. 127-2p1. U.S. Public Health Service. Bethesda. MD. (Na-
tional Cancer Institute Monograph 19).
50986 1067

A. J. Wells
.
Helsing. K. J. Sandter. D. P.. Comstock. G. W.. and Chee. E. (1988)
Heart discasc mortalitv in nonsmokers living with smokers. Am
J 6pidtmiol 127. 915-922.
Heyder. J. (1984) Studies of particle deposition and clearance in
humans in Problenu ojlnhatato.,v Toxicuy Studies P. Grosdanoff,
tt al., eds.. pp. 155-180. MMV-Medizin-Verlag. Munich.
Hitler, F. C.. McCusker. K. T.. Mazumdcr M. M. K.. Wilson. J. D..
and Bone. R. C. (1982) Deposition of sidestream ciagarette smoke
in the human respiratory tract. Am Rev Resp Dis 12S 406-J08.
Hirayama. T. (1984a) Cancer mortWity in nonsmoking women with
smoking husbands based on a large-scale cohort study in Japan.
Prey Med 13. 680-690.
Hirayama. T. (1984b) Lung cancer in Japan: Effects of nutrition and
passive smoking. in Lung cancer: Causes and prevention. M. Mis-
eli. P. Correa, eds.. pp. 175-195. Verlag Chemie International.
New York.
Hirayama, T. (1987) Passive smoking and cancer: An epidemiological
review, in Gann Monograph on Cancer Research 33. Japan Sci-
entific Societies Press. Tokyo, pp. 127-135.
Humble. C. G., Samet. J. M., and Pathak. D. R. (1987) Marriage
to a smoker and lung cancer risk, Am J Pub Health 77, 598-602.
lnoue R. and Hiraysma. T. (1987. November) Passive smoking and
lung cancer in women. Paper presented at the 6th World Con-
ferena on Smoking and Health, Tokyo.
Kabat. G. C. and Wynder. E. L. (1984) Lung cancer in nonsmokers.
Cancer 53,1214-1221.
Kabat G. C.. Diech, G. S., and Wynder E. L. (1986) Bladder cattcer
in nonsmokers. Cancer S7, 362-367.
Kalandidi. A.. Trichopoulos. D., Hatzakis. A.. Tzannes. S., and
Saracci. R. (1987) Passive smoking and chronic obstructive lung
disease. Lancet ii. 1325-1326.
Knoth. A.. Bohn. H., and Schmidt. F(1983) Passivrauchen als l.un-
genkrebs-Ursache bei Nichtraucherinnen. Medizinische Klinik 78.
66-69.
Koo. L. C.. Ho. J. H. C.. Saw. D., and Ho. C. (1987) Measurements
of passive smoking and estimates of lung cancer risk among non-
smoking Chinese females. Inr J Cancer 39. 162-169.
Lam. T. H.. Kung,1. T. M.. Wong, C. M.. Lam. W. K.. Kleevens,
1. W. L.. Saw. D. tt al. (1987) Smoking. passive smoking and
histological types in lung cancer in Hong Kong Chinese women.
Br ! Cancer 56. 673-678.
Lam. W. K. (1985) A clinical and epidemiological study of carcinoma
of lung cancer in Hong Kong. M.D. thesis. University.of Hong
Kong. Hong Kong.
Lee. P. N.. Chamberlain. J., and Alderson. M. R. (1986) Relationship
of passive smoking to risk of lung cancer and other smoking-
associated diseases. Br J Cancer $4 .97-105.
Martin. M. 1.. Hunt. S. C.. and Williams. R. R. (1986a. October)
Increased incidence of heart attacks in nonsmoking women mar-
ried to smokers. Paper presented at annual meeting of American
Public Health Association.
Martin. M. J.. Svendsen. K. H., and Kuller. L. H. (1986b. March)
Nonsmoking men married to smokers are similar to nonsmoking
men married to nonsmokers. Paper presented at the 7th Annual
Meeting, Society for Behavioral Medicine.
Melandri. C.. Tarroni. G.. Prodi. V.. DeZaiacomo. T.. Formignani
M., and Lombardi. C. C. (1983) Deposition of charged particles
in the human airways. J Aerosol Sci 14. 657-669.
Miller. G.H. (1984) Cancer. passive smoking and non-employed and
employed wives. Wtst J Med 140. 632-635.
Mitchell. R. I. (1962) Controlled measurement of smoke particle
retention in the respiratory tract. Am Rev Respir Dis 85 526-
533.
National Centei for Hea)th Statistics (1986) Health United States
1986. U.S. Dept. of Health and Human Services, Public Health
Service. Hyzittsville. MD, 106-109.
National Research Council (1986) Environmental tobacco smoke
measuring exposures and assessing health effects. National Acad-
emy Press. Washington. D.C.
Office of Technology Assessment (1985) Smoking related deaths and
financial costs: Office of Technology Assessment. U.S. Congress.
Washington. D.C. Office on Smoking and Health (1979-85) Bib-
liography on s,mokitlg and health. U.S. Public Health Service.
Rockville, MD. and Smoking and Health Bulletins after 1985.
Penn. A.. Batastini. G.. Solomon. J.. Burns. F.. and Albert. R. E.
(1981) Cancer $ej 41. 588-592.
Penn. A.. Garte. S, J., Warren. L.. Nesta, D., and Mindich. B. (1986)
Transforming gene in human atherosclerotic plaque DNA. Proc
Nat Acad Sci 83, 7951-7955.
Pershagen 0.. Hn4bec. Z., and Svensson. C. (1987) Passive smoking
and lung cancer':in Swedish women. Am J Epidemiol US. 17-.d.
Repace. J. L. and kowrey. A. H. (1985) A quantitative estimate of
twnsmokeri lung cancer risk from passive smoking. Environ !nr
11. 3-22.
Reynolds, P.. Kaplan. 0. A., and Cohen. R. D. (1987, June) Passive
smoking and cane,er incidettce: prospective evidence from the Ala-
meda County study. Paper presented at the Society for Epide-
miologic Research. Amherst. Massachusetts.
Rothman. K.1. and "ce. l. D. (1982) Epidemiologic Anal,vsi's with
a Programmable Calculator. pp. 5-17. Epidemiology Resources.
Chesnut Hill. Massachusetts.
Rothman. K. l. (1986) Modern Epidemiology. pp. 139-147.
184-190. Little. Brown, Boston.
Russell, M. A. H.. Jarvis. M. 1.. and West. R. 1. (1986) Use of
urinary nicotine cohcentrations to estimate exposure and mortality
from passive smoking in non-smokers. 8r J Addiction 81. 317-
323.
Sandler. D. P.. EversQn, R. B.. and Wilcox. A. J. (1985) Passive
smoking in adulthood and cancer risk. Am J Epidemiol 121. 37-
48.
Sandler. D. P.. Everson. R. B.. and Wilcox. A. J. (1986) Cigarette
smoking and breast cancer. Arrt J Epideamiol 123. 370-371.
Stbber, W. (1984) Lung dynamics and uptake of smoke constituents
by nonsmokers-a lurvey, Prey Med 13, 589-601.
Svettdsen. K. H., Kulk'~ ,[.. H.. and Neaton. J. D. (1987) Effects of
passive smoking in the multiple risk factor intervention trial. Am
J Epidemiol 126, 70-795.
Trichopoulos. D.. Kalandidi, A., and Sparros. L. (1983) Lung cancer
and passive smoking: Conclusion of the Greek study. Lancer ii.
677-678.
U.S. Surgeon General, (1986) The health consequences of in-
voluntary smoking. a report of the Surgeon General. DHHS
(CDC) 87-8398, U.S. Public Health Service. Rockville. Mary-
land.
Vandenbroucke. J. P.. Verheesen, l. H. H., deBruin. A.. Mau-
ritz. B. J.. Van der He,ide-Wessel. C., and Van der Heide. R. M.
(1984) Active and pas#ive smoking in married coupks: Results of
25 year follow up. Br,btd J 288. 1801-1802.
Wald, N. J., Nanchanal. K.. Thompson. S. G., and Cuckle. H. S.
(1986) Does breathing" other people's tobacco smoke cause lung
cancer? Br Mtd J 293. 1217-1222.
Wells. A. J. (1986) Misclassification as a factor in passive smoking
risk. Lancet ii, 638.
Wu. A. H.. Henderson. B. E.. Pike. M. C.. and Yu. M. C. (1985)
Smoking and other risk factors for lung cancer in women. ! Nat
Cancer Insr 74. 747-751.

.
259
Adult mortality from passive smoking
r
Table Al. Annual U.S. male lung cancer dcaths from passive smoking.
Relative Risk
Constant at 2.1
Age of
Death Nevcrsmoker
Death Rate
perr100.000 Nonsmoker
Population
1000's
Fraction
Exposed Exposed
Popqlation
1000's
Excess
Death Rate
Deaths
35-39 1.8 5156 0.74 3815 1.09 42
40-44 2.9 4136 0.72 2980 1.78 53
45-49 4.5 3477 0.70 2440 2.80 68
50-54 7.0 3431 0.66 2260 4.46 101
55-59 11 3423 0.63 2155 7.15 154
60-64 16 3489 0.59 2054 10.7 219
65-69 23 3150 0.54 1695 15.9 269
70-74 33 2443 0.45 1099 24.3 267
75-79 49 1712 0.37 633 38.3 242
80-g4 72 921 0.27 249 61.1 152
85+ 95 516 0.08 41 96.0 39
Totals 15.9 31944 0.61 19320 8.26 1606
Appendix A
Details of death calculations
Tables A1 and A2 show the details of the death calculations
for male lung cancer and female cancer other than lung and
are similar in all respects to Table 6 in the text except that
no declining relative risk calculation is shown for male lung
cancer since the evidence that was available (Hirayama,
1984a) indicated no such decline.
In Table A3 the details are given for the development of
the never smoker relative risks for heart disease that. were
used in the death calculations. As noted in the text, the 1963
neversmoker heart death rates by 5-year intervals were ob-
tained by dividing the never smoker coronary heart deaths in
Hammond's (1966) appendix. Table 14, by the person years
in his appendix tables 2a and 2b. Reduction factors to account
for the change in heart death rates between 1963 (end of
Hammond's study) and 1984 were then developed by 10 year
age intervals from the age specific heart death rates in table
24 of Health U.S.1986 (NCHS,1986). These reduction factors
were modified for the fractions thought to be due to smoking
which were taken from a staff report of the Office of Tech-
nology Assessment (OTA. 1985) to yield a combined never
smoker reduction fattor, interpolated back to 5-year age in-
tervals, for application to the Hammond never smoker death
rates. These modified rates, which are for enrollment age and
therefore about 2 years younger than age of death. were then
plotted against age of death on semi-log graph paper. Trend
lines were then drawn through the female and the male points
to yield the values in the last column of Table A3.
Tables A4 and AS are simply the details of the heart death
calculations as in Tables 6. Al, and A2 for cancer.
The deaths shown in Table 7 resulting from the corrections
for misclassification were calculated from the relative risks in
lines 4 of Table 5 taken as constant over the age range. The
modification of the observed relative risks for smoker mis-
classification as shown in Table 5 are based on misclassified
smoker relative risks calculated as follows. Based on as yet
unpublished work of Wells on misclassification it was assumed
that self-reported current smoker relative risks for male and
female lung cancer in the U.S. and U.K. were 11 and 7, and
4.6 and 2.7 lot male and female current smokers in Japan
Table A2. Annual U.S. female deaths from cancer other than lung from passive smoking.
Exposed Relative Risk
Constant at 1.16 Relative
Risk
Neversmoker Population Declining
Age of
Death Death Rate
per 100.000 (Table 6)
1000's Excess
Death Rate
Deaths
RR
Deaths
35-39 28 5781 3.9 225 4.5 1321
40-44 48 4252 6.7 285 2.9 1411
45-49 80 3423 11.2 383 2.0 1449
50-54 125 3355 17.6 589 1.56 1579
55-59 190 3495 26.8 937 1.30 1591
60-64 265 3228 37.7 1219 1.18 1352
65-69 355 2912 51.1 1487 1.12 1144
70-74 470 2030 68.7 ' 1395 1.08 729 Ln
75-79 600 1472 89.0 1310 1.05 431 m
80-84
85+ 750
900 537
100 114.7
141.7 627
142 1.034
1.022 138 W
co
20 m
i Totals 256 30595 28.1 8599 11165 N
m
m
~o

260 A. J. Wells
Death rates from
Hammond (1966)
Age at enrolled age
Range per 100600
1984
1984 Neversmoker
Decline. Fraction Neversmpker Hammond's heart
in heart of decline Death Rate N.S. D.R. death rate
DR's Sfc due to as S4 of 1963 corrected by age of
1963-84 smoking (smoothed) for decline death
-Table A3. Development of 1984 neversmoker heart death rates versus age.
Feinales:
35-39 7.1 49 3.5 2.0
.i8 0
40-44 14.1 55 , 7.7 4.4
45-49 20
4 60 ' 2
12 2
10
. 37 0 . .
50-54 45.5 63 ' 28.7 23
55-59 104
36
0 64 66 51
60-64 243 64 156 113 . a
65-69 475 .
64 304 24Q G
70-74
961 37 0 .
64 .. .
615'. .
480 .
75-79 1648 63 1072 870
35 0
80-84 2774 70 1942 1550
85 + - 21 0 79 - 2770
Males:
35-39
0
76
0
20
48 S0
40-44 79.5 77 . 61 36
45-49 85.5 78 67 68
42 50
50-54 220 77 169 128
55-59 397 75 298 237
37.5 25
60-64 741 75 556 412
65-69 1089 76 827 730
32 25
70-74 1936 76 1472 1150
75-79 2639 77 2024 1850
25 10
80-84 4374 81 3543 _950
85+ - 14 10 86 - 4700
(Hirayama. 1984a). The 5% of ever smokers who were as-
sumed misclassified as never smokers were assumed to consist
of 23% light current smokers and 77% long term exsmokers.
The excess risks for current. self-reported smokers were re-
duced by 2/3 to yield relative risks for misclassified current
smokers and by 11/12 for relative risks of misclassified
exsmokers essentially as was done by Wald a al. (1986). This
resulted in misclassified ever smoker relative risks of 2.4, and
1.85 for males and females in the U.S. and U.K. and 1.5 and
1.25 for Japan. Worldwide misclassified smoker relative risks
were then calculated to be 1.8 for males and 1.6 for females
based on the proportion of western" and "eastern" cases.
The false «lativt;', ritks shown on lines 2 in Table S were then
calculated using t'he formulae in Wells' unpublished work.
For female cancer other than lung, the smoker relative risk
of 1.05 was taken from Hammond (1966) and used as is since
the effect is too small to make any difference. For ischemic
heart disease the ever smoker relative risks from Hammond
Table A4. Annual U. S. female heart deaths from passiye smoking.
Relative Risk Relative
Neversmoker Exposed Constant at 1?3 Risk
D
h R P
l
i
Age of eat
ate
per 100.000 opu
at
on
(Table 6)
Excess Declining
Death (Table A3) 1000's D.R. Deaths RR Deaths
35-39 2.0 5781 0.38 22 4.0 91
40-44 4.4 4252 0.84 36 2.0 97
45-49 10.0 3423 1.91 65 1.32 85
50-51 23 3355 4.4 138 1.17 114
55-59 Sl 3495 9.8 344 1.17 265
60-64 113 3228 22.1 713 1.17 548
65-69 240 2912 47.7 13$S ', 1.17 1062
70-74 480 2030 97.2 1973 ' 1.17 1505
75-79 870 1472 180 2647 1.17 2010
80-8i 1550 547 334 1828 ' 1.17 1374
85+ 2700 100 607 607 1.17 451
Totals 291 30595 31.9 9768 ' 7602

- ~ Adult mortality from passive smoking 261
Table A5. Annual U. S. male hean deaths from passive smoking.
Relative Risk Relative
Neversmoker
D Exposed
P Constant at 1.31 Risk
eath Rate opulation Declining
Age of 1,, pe r 100,000 (Table A I) Excess
Death (Table A3) 1000's D.R. Deaths RR Deaths
35-39 20 3815 4.9 187 5.2 780
40-44 36 2980 8.9 265 3.0 879
t 45-49 68 2440 16.9 411 1.92 929
S0-54 128 2660 32.1 724 1.42 951
SS-59 237 21SS 59.8 1289 1.28 1201
60-64 412 2054 105 2157 1.28 2009
65-69 730 1695 189 3195 1.28 2972
70-74 1150 1099 304 3341' 1.28 3103
75-79 1850 633 S00 3162 1.28 2933
80-8.1 2950 249 819 2039 1.28 1887
85+ 4700 41 1377 565 520
Totals 521 19.120 89.3 M7335 1816i
(1966) were taken as 2.3 for males and 2.0 for females. The
excess risks were reduced by 2/3 to yield relative risks for
misclassified ever smokers of approximately 1.4 for males and
1.3 for females. These were used worldwide with Wells' un-
published formulae to calculate the false hean disease relative
risks shown on lines 2 of Table S.
Appendix B
Relative risks for all causes ojdeath and for
emphysema and chronic obstructive lung disease
Data relating all causes of death with passive smoking for
females have been reported for four prospective studies to-
talling9537 cases as shown in Table B 1. The combined relative
risk is 1.165 with 95% confidence limits of 1.11 to 1.22. The
only male data available are 75 cases from Gillis et al. (1984)
with_a relative risk of 1.0 so no male analysis was made.
The calculation of the total number of female deaths from
all causes for passive smoking is shown in Table B2. The total.
34.164. is considerably larger than the total for cancer plus
heart of 19.359 shown in Table 7. Some of the difference is
due to uncertainties in the calculations, but other causes of
death that might contribute to the all cause total, based on
data in a private communication from Dr. Hirayanka, are
cerebrovascular disease, other heart disease, diabetes, and
ulcer.
Hirayama (private communication. also reported preli-
minarily at Sth World Conference on Smoking and Health,
Winnipeg, 1983) provides data relating deaths from emphy-
sema with passive smoking in women. His relative risk. based
on 106 cases ls ;.3 with 95% confidence limits of 0.85 to 2.05.
Kalandidi et al,. (1987) report incidence data for chronic ob-
structive lung disease based on 103 cases with an adjusted
relative risk of about 1.4. l,ee et al. (1986) report incidence
data for chronic bronchitis from spouse exposure. Based on
17 cases the adjusted relative risk is 1.22. A weighted average
of these three relative risks would be about 1.35. The only
neversmoker death rate we have is from Hammond (1966)
for emphysema at 2 x 10-s. Assuming 76% exposure, the
excess death rate for passive smoking using Eq. (2) would be
0.55 x 10-s and the total deaths for an exposed population
of 30.6 million would be about 170. Even if this number is
doubled to take into account deaths from forms of chronic
obstructive lung disease other than emphysema. it is still far
below the total for cancer and ischemic heart disease.
Table B1. Female relative risks for all causes of death from passive smoking.
l
T All
Exposures Mantel
Trend
Locale ota
Cases RR 95% C.L. 1-tail p
Cohort Studies:
Hirayama (1987)
Japan
9106
1.17
l.1?- 1.23
0.01X101
Gillis cr al. (1984) Scotland 102 1.45 0.91-2.30
Garland ci al. (1985) California 79 1.06 0.65-1.73
Vandenbroucke et al
(1984)° Holland 250 79
0 57-1
0
09
. . .
.
-~.----
Combined Chort: 9537 1.165 '' 1:11-1.2:
'Dr. Hirayama (private communication) provided the data necessary to calculate these items.
'Data from 25 year follow up. Relative risk was 0.89 (0.50-1.62) for 15 year follow up. This study
is weak
in that exsmoking women were included among the "nonsmokers." and rionsmo{;ing women exposed to
cxsmoker husbands were included in the 'nonexposed." The weakness of the study is emphasized in
that
the smoking women had a lower overall death rate (33.4rXc) than the nonExposed nonsmokers (38.1rr).

262 A. J. Wells
r
Death rates for txposed and not exposed populations were
obtained by dividing the observed deaths in each category by
person years which were equated to the mid-point populations
multiplied by the years of followup. The rate difference was
then obtained by subtracting the nonexposed death rate from
the exposed death rate. Variances and weights were calculated
by Rothman's formulae. The combined rate difference was
obtained by summing the weighted rate differences and di-
viding by the sum of the weights. Confidence limits (95%)
were equated to the rate difference s 1.96 (variance)".
The results of these calculations are summarized in Table
Cl. The cohort data were also combined using Program 7 of
Rothman and Boice (1982) with results essentially identical
to those shown in Table CI for direct pooling. The relative
heterogeneity of the relative risks (RR) vs. the rate differences
(RD) can be approximated by considering the range of RR-
I versus the range of RD. The range of RR-1 is from 0.16 to
2.6 for a factor qf 46.3. The range of the rate differences is
3.7 to 262 or a fac+tor of 71. The ratio for the two large studies.
Helsing et a!. (19$8) and Hirayama (1984b), for RR-1 is 0.24/
0.16 = 1.5 and for RD is 20.7/3.7 = 5.6. The 95% confidence
limits for the rate ratio combination is tighter than for the
rate difference combination. Also. the Hirayama study dom-
inates the rate difference aggregation much more than in the
rate ratio aggregation, providing 64% of the combined weight
(last column of Table Cl) in the rate difference case vs. only
17% of the combined weight in the rate ratio case.
n
Table Cl. Rate difference calculations for female ischemic hean disease.
Relative Risk
from Table 4 Rate difference
x 14`
Weights
RD x
Total
Cases
RR
95% C.L.
RD
95% C.L. for RD
x 10' weight
x 10''
Cohort Studies:
Hirayama (1984b)
494
1.16
0.9- 1.4
3.7
+-2.1- 9.6
1110
41.4
Gillis et al. (1994) 21 3.6 0.9-13.8 169.1 y 3Q.7-307.6 2 3.4
Garland etal. (1985) 19 3.5 0.9-13.6 262.2 36.0-a88.4 0.8 2.0
Helsing a al. (1988) 988 1.24 1.1- 1.4 20.7
_ '- 0.2- 41.6
..,....~.~.. 88 18.2
Combined Cohort 1522 1.23 1.1- 1.4 5.4 70.2- 11.1 1201 65.0
'j.able B2. Annual U.S. female deaths from all causes from passive smoking.
Decrement Corrected Neversmoker Relative Risk
due to heart Neversmoker death rate Constant at 1.165
death
at ath
d
t ct
d i
l
P F
i
r
e
1963-8a e
ra
e at
enrolled age corre
e
to age of death on
opu
at
tirposed ract
on
of population
Excess
pet100.000 per 100.000 per 100.000 1000's exposed D.R. Deaths
35-39 136 3.6 132.4 120 5781 0.94 17.1 991
40-44 178 6.4 171.6 155 4252 0.92 22.2 944
45-49 254 8.2 243.8 212 3423 0.89 30.5 1044
50-54 352 16.8 335.2 300 3355 0.87 43.3 1452
55-59 561 38 523 445 3495 0.84 64.5 2254
60-64 867 87 780 675 3228 0.77 98.8 3190
65-69 1492 171 1321 1070 2912 0.70 158.3 4609
70-74 2585 346 2239 1830 2030 0.59 275.2 .5586
75-79 4790 576 4214 3250 1472 0.49 496.1 7303
80-84 8408 832 7576 6000 5i7 0.29 944.8 5168
85+ - - - 10.000 100 0.10 1623 1623
Totals 30595 111.7 3416a
Deaths per million total population 143
Neversmoker
Death Rates
from Hammond
(1966) at
Age enrolled age
Range per 100.000
Lee eral. (1986) report data on chronic bronchitis life long
nonsmoking in males exposed to a smoking spouse. Based on
nine cases the adjusted relative risk was 0.34. However, for
general exposure (4 cases) a positive relative risk was ob-
served. No analysis of these data was attempted.
Appendix C
Rate difference model for assessing female ischemic
heart deaths from passive smoking
A rate difference or absolute risk model was investigated
for female ischemic heart disease in order to compare it to
the relative risk models in ability to translate experience from
one type of culture to another. Female ischemic heart disease
was chosen because considerable data exist and because heart
disease is the largest contributor to total deaths. Also. the
relative risk model seems already to be well established for
lung cancer (Wald et al., 1986; Blot and Fraumeni. 1986) so
a comparison in another disease category appeared to be ap-
propriate.
Data from the four cohort studies (see Table 4) were com-
bined using the direct pooling equations described on page
183 in Rothman (1986). The two case/control studies were
omitted. Although their combined rate difference was essen-
tially the same as that for the cohort studies, no good way
could be found to combine it with that from the cohort studies.

t
Adult mortality from passive smoking 263
Table Dl. Regional particle deposition from mouth breathing of side stream smoke.
Aero-
Relative Fraction of inhaled
particle mass deposited"
Mass
i V
l i
d
d
dynam
c o
ume Mass te
as
epos
diameter Cube of Relative (weight) Distribution mouth tracheo- % di total
µm diameter eorjcsntration' per 0.1µm °k throat bronchial alveolar mass inhaled
0.20 .008 1.5 0.006 0.3 0 0 0.13 0.04
0.25 .016 6.5 0.051 2.4 0 0 0.122 0.29
0.30 .027 10.0 0.135 6.4 0 0 0.115 0.74
0.35 .043 13.0 0.280 13.2 0 0 0.108 1.43
0.40 .064 13.0 0.416 19.6 0 0 0.10 1.96
0.43 .091 6.5 0.296 14.0 0 0 0.105 1.47
0.50 .125 3.5 0.328 15.5 0 0 0.11 1.71
0.60 .216 1.25 0.270 12.7 0 0 0.115 1.46
0.70 .343 0.5 0.172 8.1 0 0 0.12 0.97
0.80 .512 0.25 0.128 6.0 0 0 0.13 0.78
0.90 .729 0.05 0.036 1.7 0 0 0.14 0.24
1.00 1.0 0 0 0 0 0 0.15 0_00
2.118 99.9 11.08
From Hiller u a!. (1982). Fig. 1.
"From Heyder (1984). Table 1. 250 cm'/second mean flow rate. 4 second breathing cycle.
This domination of the rate difference model by the Jap-
anese study is evident from some rough death calculations.
Use of the combined rate difference (5.4 x l0-`) with the
exposed female population from Table A4 (30.6 million)
yields total deaths of 1.652 compared with 9.768 calculated
from the constant rate ratio model. When the rate differences
are plotted against age of death and weighted accordingly it
is found that the "western" rate differences increase sharply
with age whereas the Japanese rate difference stays constant
at about 4 x 10''. Constructing a weighted average of these
'western" and "eastern" death rates for each of the 5 year
age ranges and multiplying by the corresponding exposed pop-
ulations yields a total of about,2,100 deaths compared with
7.602 in the se;ond relative risk model. Use of the Japanese
data alone yields about 1.200 deaths. Use of only the west-
ern" data (Gillis et al.. 1984; Garland et al.. 1988; Helsing
et al.) at a constant rate difference yields 7.950 deaths while
use of "westerA" data with the rate difference varying with
age yields about 30.000 deaths. Thus. the death calculations
using rate differences are quite volatile. Also, it is evident
that with the rate differences it is not feasible to carry over
the "eastern" experience, in ischemic heart disease at
least, for use in a"western" setting. Accordingly. it was
concluded that'the absolute risk model is not as suited to
combining risks for passive smoking as the relative risk
models.
Table D2. Regional particle deposition from nose breathing of sidestream smoke.
Aero-
d
Fraction of inhaled
particle mass deposited" Mass deposited as
g~r
of total mass
ynamic
diameter Mass
distribution
mouth
tracheo- inhaled
µm K nose throat bronchial alveolar nose alveolar
0.20 0.3 0 0 0 0.19 0.00 0.06
0:25 2.4 0.005 0 0 0.172 0.01 0.41
0.30 6.4 0.01 0 0 0.155 0.06 0.99
0.35 13.2 0.015 0 0 0.138 0.20 1.82
0.40 19.6 0.02 0 0 0.12 0.39 2.35
0.45 14.0 0.03 0 0 0.122 0.42 1.70
0.50 15.5 0.04 0 0 0.125 0.62 1.94
0.60 12.7 0.05 0 0 0.129 0.64 1.63
0.70 8.1 0.06 0 0 V.13 0.49 1.u5
0.80 6.0 0.077 0 0 w33 0.46 0.811
0.90 1.7 0.093 0 0 41.137 0.16 0.23
1.00 0.0 0.11 0 0 0.14 0.(10 001
3.45 1'.99
'From Table Dl.
From Heyder (198a). Table 2. 250 em' second mean flow rate. 4 second brjeathing cycle.
~

.264
A. J. Wells
Table D3. Smoke Particle deposition patterns in direct and passive smoking.
Direct Smoking Passive Smoking DirectrPassive
Entry site
Particulate inhaled per day. mg. Mouth
240 Nose
2.8
86
Particle Size inhaled. µm 0.7 0.4
Particle size exhaled. µm 0.7 0.4
Retained in nose. °k 0 3.5
Retained in mouth. % 25 0
Retained in tracheo-bronchial region. % 35 0
Retained in near alveolar region.'t: 11 0
Retained in deep alveolar region. ck 9 J3
Total retained. % 80 16.5
Particulate retained, total, mg. 192 0.16 417
Particulate retained, alveolar, rrig. 48 0.36 133
Particulate retained, deep alveolar. mg. 22 0.36 61
Appendix D
Dose consideratforu
As noted in the text, there is a wide difference between
the observed disease ratio between passive and active smokers
and the ratio of cigarette smoke particulate retained by each.
Also, the cancer sites appear to differ. On the assumption
that part of these differences may be due to differences in
deposition sites between passive smoking and active smoking,
calculations were carried out to try to pinpoint these differ-
ences.
The calculations for passive smoking are reasonably
straightforward. Stober (1984) has summarized all the uncer-
tainties in this type of calculation. Nevertheless, the best ap-
proach appears to be to use the data of Hiller et al. (1982)
for the particle size range of side stream smoke, centering
around 0.4 µm, and the mathematical lung model of Heyder
(1984) for inert particles. Integration of these two data sets
yields a, distribution of deposited weights by particle size for
mouth breathing (see Table D1) which, when summed. yields
exactly the total deposition observed by Hiller et al., (1982)
indicating that the Heyder model holds for passive smoking.
The same inhaled particle size distribution can then be applied
to Heyder's nose breathing case (see Table D2) which yields
nasal deposition of 3.5% and deposition in the alveolar region
of the lung of 13.0%. The model predicts zero deposition for
both the mouth/throat and the tracheo-bronchial regions.
From the deposition curves of Gerrity et al. (1979) (Fig. 2)
for iron oxide extrapolated to a particle size of 0.25 µm (which
is equivalent to an aerodynamic diameter of 0.4 µm) it appears
that all of the lung deposition from passive smoking probably
occurs deep in the alveolar region at generation 19 or beyond.
Black and Pritchard (1984) have determined the half-time for
alveolar retention for direct cigarette smoke to be 17 hours
indicating that the smoke particles dissolve and clear into the
blood or lymph system. There is every reason to believe that
the passive smoke particles clear the same way.
With direct smoking there has so far been no model de-
veloped that explains the observed phenomena, namely that
the inhaled particle size is about 0.7 µm. that 70% to 80%
of the inhaled smoke is retained, that 15 to 35% is retained
in the mouth, and that the exhaled particle size is also about
0.7 µm. The Heyder model at 0.7 µm would predict total
retention of only 12%. To achieve 75% retention, the Heyder
model would require an effective particle size of 6.5 µm. Main
stream smoke is known to agglomerate, but if it agglomerated
to 6.5 µm, the exhaled smoke, according to the Heyder
model, would be about 6 µm. much too large compared to
that observed. Mitchell (1962) observed that direct smoke
particles grow in the mouth to. about 1.15 µm and that the
smoke exhaled froM the lung after a 5 second retention period
had a mass mediari diameter size of 0.65 µm. Let us assume
that the 0.65 µm part of the smoke follows Heyder's model
and that 20% of the total smoke inhaled was exhaled, all from
the 0.65 µm fraction. The inhaled part of the smoke corre-
sponding with the 0.65 µm part exhaled would have the same
particle size and would deposit about 12%. deep in the al-
veolar region. This is 12% of 22.7% of the total smoke in-
haled. or 2.7% of;the total inhaled smoke. The balance of
the inhaled smoke (17%) would have a larger average particle
size, about 1.3 µm. Black and Pritchard (1984) found. based
on clearance data, that the rates of alveolar deposition to
alveolar plus tracheo-bronchial deposition in direct smoking
is 0.36. Also, as nQted, some amount, say 25% of the total
inlet smoke should deposit in the mouth and throat, all of
which would have tp come from this larger size fraction. Sum-
marizing these numbers, of the 100 - 20 - 25 = 35% of
total smoke particulate that reaches the lung and is not ex-
haled. 0.64 x 55 * 35% deposits in the tracheo-bronchial
region and 0.36 xtS - 20% deposits in the alveolar region.
We have already accounted for 3% of the alveolar deposition
from the 0.65 µm particles. The remaining 17% would come
from the larger particles. Based on the alveolar/tracheo-bron-
chial split and usingthe curves of Gerrity ct al. (1979) it would
be. expected that about 2/3 of the alveolar deposit or 11%
would deposit in the 'near" alveolar region, generations 16-
18, and 6% in the "deep" alveolar region. generations 19-
21. for a total 'deep" alveolar deposition of 9%. These cal-
culations are summarized in Table D3.
Just what the mechanisms are for so much direct smoke
deposition remains unclear. Certainly impaction and sedi-
mentation (the Heyder model) do not account for it. Stober
(1984) suggests that electrical charges in the newly generated
smoke particles (se ~Aetandri et at., 1983) may account for
some of it. Arlothe>~possible mechanism is the cloud settling
phenomenon as de4cribed ~by Fuchs (1964).
Whatever the 'trt charlisrtt, a reasonably clear idea of the
regional deposition ~tjttertts from direct and passive smoking
a,

,,
. _.. ... ..~~~~. num passY.e smoking
can be obtained as shown in Table D3. The nasal deposition
from passive smoking could account for the observed nasal
sinus cancer. Also. if the observation of Balin er ol. (19$6) is
correct that there is a direct passage for toxics from the nose
to the brain. it could also account for the observed brain
cancer. In the deep alveolar region the ratio of direct to pas-
r-
:hi
sive deposition is much closer to the inhaled ratio than to the
"total retained" iatio. It is from the deep alveolar region that
the smoke panicl,es are solubilized and cleared into the blood
and lymph systems possibly to cause cancers of the liver,
breast and endocrine glands, leukemia. lymphoma and ar-
terial plaques.
